HBEGF and head and neck squamous cell carcinoma: HNSCC patients with lower expressions of HB-EGF (p = 0.01), TIMP-1 (p = 0.0063) showed a significantly higher 5 years survival rate compared to those HNSCC patients with higher expressions of these factors (Fig. 8 D, Fig. 8Q).